Edmundo Yrigoyen
Internal Medicine · Houston, TXNPI 1669530697
Payments from drug & device makers
Across 172 payments — averaging $21.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$929
- Novo Nordisk$616
- Lilly USA, LLC$420
- Johnson & Johnson$366
- Amarin Pharma, Inc.$295
- AbbVie$191
- plus $807 from 18 others
What the payments were for
- Food & beverage$3,60299%
- Education$231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 35 | $929 |
| Novo Nordisk | 24 | $616 |
| Lilly USA, LLC | 21 | $420 |
| Johnson & Johnson | 11 | $366 |
| Amarin Pharma, Inc. | 17 | $295 |
| AbbVie(2 entities) | 14 | $191 |
| Pfizer | 7 | $162 |
| Kowa Pharmaceuticals America, Inc. | 15 | $140 |
| Mannkind Corporation | 4 | $69 |
| GSK | 3 | $64 |
| Novartis | 3 | $59 |
| Amgen | 3 | $43 |
| Merck | 3 | $42 |
| Dexcom, Inc. | 2 | $39 |
| Melinta Therapeutics, LLC | 1 | $33 |
| Gilead | 1 | $25 |
| Nestle Healthcare Nutrition Inc. | 1 | $21 |
| Radius Health, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,625 in reported general payments places this provider in the 85th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pravastatin Sodium | 12 | $451 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Houston
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Aung NaingHouston$30.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Nicholas ShortHouston$17.6M
- Isabella GlitzaHouston$14.8M
- Murtaza MussajiHouston$13.1M
- Hussein TawbiHouston$12.6M
- Hans LeeHouston$11.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.